Noam Scheiber argues that embryonic stem-cell research won’t do much to help Democrats, because the country is roughly evenly divided on the larger issue of whether biotechnology needs to be restrained. I think his conclusion is correct, but I think that the biggest reason it’s correct is that not many voters care enough about embryonic stem-cell research to learn much about it, let alone to vote on it.

About the Author
Ramesh Ponnuru is the editor of National Review, a columnist for the Washington Post, and a fellow at the American Enterprise Institute.
Advertisement
Advertisement





Comments